Lauran Neergaard

Read the latest stories and analysis from Lauran Neergaard.

FDA approves return of drug for morning sickness

FDA approves return of drug for morning sickness

Lauran Neergaard · April 9, 2013 2:08 pm

This undated image made available by Teva Women's Health shows the packaging for their Plan B One-Step (levonorgestrel) tablet, one of the brands known as the "morning-after pill." In a scathing rebuke of the Obama administration, a federal judge ruled Friday that age restrictions on over-the-counter sales of the morning-after pill are "arbitrary, capricious and unreasonable" and must end within 30 days. The ruling by U.S. District Judge Edward Korman of New York means consumers of any age could buy emergency contraception without a prescription _ instead of women first having to prove they're 17 or older, as they do today. And it could allow Plan B One-Step to move out from behind pharmacy counters to the store counters. (AP Photo/Teva Women's Health)

Risk for Obama in pursuing morning-after pill case

Lauran Neergaard, Josh Lederman · April 6, 2013 4:00 am

New world strategy aims to eradicate polio by 2018

New world strategy aims to eradicate polio by 2018

Lauran Neergaard · April 2, 2013 9:44 pm

Panel: Thumbs down on anthrax vaccine test in kids

Panel: Thumbs down on anthrax vaccine test in kids

Lauran Neergaard · March 19, 2013 4:10 am

Report: 1 in 3 seniors dies with, not of, dementia

Report: 1 in 3 seniors dies with, not of, dementia

Lauran Neergaard · March 19, 2013 4:07 am

Huge study: 5 mental disorders share genetic links

Huge study: 5 mental disorders share genetic links

Lauran Neergaard · February 27, 2013 11:30 pm

CDC chief: Spending cuts threaten public health

CDC chief: Spending cuts threaten public health

Lauran Neergaard · February 22, 2013 9:46 pm

Doc groups issue list of overused tests, therapies

Doc groups issue list of overused tests, therapies

Lauran Neergaard · February 21, 2013 5:28 am

NIH chief: Cuts put vital medical research at risk

NIH chief: Cuts put vital medical research at risk

Lauran Neergaard · February 14, 2013 7:07 pm

Report: Tracking system needed to fight fake drugs

Report: Tracking system needed to fight fake drugs

Lauran Neergaard · February 13, 2013 10:26 pm

Clues to why most survived China melamine scandal

Clues to why most survived China melamine scandal

Lauran Neergaard · February 13, 2013 8:27 pm

Scientists to resume work with lab-bred bird flu

Scientists to resume work with lab-bred bird flu

Lauran Neergaard · January 23, 2013 7:17 pm